Imaging of secondary pulmonary changes in central bronchial carcinomas by F-18-FDG-PET;Darstellung sekundarer pulmonaler veranderungen bei zentralen bronchialkarzinomen in der F-18-FDG-PET

NuklearMedizin

Volumn 38, Issue 8, 1999, Pages 323-327

  Briele, Bernd ^a   Willkomm, Petra ^b   Grunwald F ^b   Ruhlmann, J ^b   Biersack, H J ^b  

^a KLINIKUM FULDA   (Germany)

^b NONE

Author keywords

Atelectasis; Bronchial carcinoma; Dystelectasis; FDG PET; Retention pneumonia; Secondary pulmonary changes

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; TUMOR LOCALIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; LUNG DISEASE; LUNG TUMOR; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; SCINTISCANNING;

AGED; CARCINOMA, BRONCHOGENIC; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032764689     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632230     Document Type: Article

References (21)

1. Baum RP, Rust M, Adams S et al. Influence on patients management by whole-body F-18-FDG-PET for preoperative staging of non small cell lung cancer. J Nucl Med 1996; 37: 121P.
2. Baum RP, Presselt N, Bonnet R. Lungenrundherde und nichtkleinzelliges Bronchialkarzinom. In: PET in der Onkologie. Ruhlmann J, Oehr P, Biersack HJ (eds.). Berlin, Heidelberg, New York: Springer 1998; 89-105.
3. Bury T, Paulus P, Dowlati A et al. Staging of the mediastinum: value of positron emission tomography in non-small cell lung cancer. Eur Respir J 1996; 9: 2560-4.
4. Bury T, Dowlati A, Paulus P et al. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med 1996; 23: 204-6.
5. Guhlmann A., Storck M, Kotzerke J et al. Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emmission tomography (PET). Thorax 1997; 52: 438-41.
6. Gupta NC, Frank AR, Dewan NA et al. Solitary pulmonary nodules: detection of malignancy with PET with fluorine-18-fluorodeoxyglucose. Radiology 1992; 183: 441-4.
7. Hughes JMB. F-18 fluorodeoxyglucose PET scans in lung cancer. Thorax 1996; 51: 16-22.
8. Jones HA, Clark RJ, Rhodes CG et al. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994; 149: 1635-9.
9. Kapucu LO, Meltzer CC, Townsend DW et al. Fluorine-18-Fluorodeoxyglucose Uptake in Pneumonia. J Nucl Med 1998; 39: 1267-9.
10. Knight SB, Delbeke D, Stewart JR et al. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patient with and without a prior history of prior malignancy. Chest 1996; 109: 982-8.
11. Lowe VJ, Duhaylongsod FG, Patz EF et al. Pulmonary abnormalities and PET data analysis: a retrospektive study. Radiology 1997; 202: 435-9.
12. Lowe VJ, Hoffman JM, DeLong DM et al. Semiquantitative and Visual Analysis of FDG-PET Images in Pulmonary Abnormalities. J Nucl Med 1994; 35: 1771-6.
13. Nettelbladt OS, Sundin OE, Valind SO et al. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 1998; 39: 640-7.
14. Patz EF, Lowe VJ, Hoffman JM et al. Focal pulmonary abnormalities: evaluation with fluorine-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487-90.
15. Patz EF, Lowe VJ, Hoffman JM et al. Persistent or recurrent bronchogenic carcinoma: detection with PET and fluorine-18-fluordeoxyglucose PET scanning. Radiology 1994; 191: 379-82.
16. Quint LE, Francis IR, Wahl RL et al. Preoperative staging of non-small-cell lung carcinoma of the lung: Imaging methods. AJR 1995; 164: 1349-59.
17. Sasaki M, Ichiya Y, Kuwabara Y et al. The usefullness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with x-ray computed tomography. Eur J Nucl Med 1996; 23: 741-7.
18. Steinert HC, Von Schulthess GK, Weder W. Effektivität der Ganzkörper-PET mit FDG beim Staging des nichtkleinzelligen Bronchuskarzinoms bei 100 Patienten. Nuklearmedizin 1998; 37: V135.
19. Vansteenkiste JF, Stroobants SG, De Leyn PR et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-9.
20. Wahl RL, Quint LE, Greenough RL et al. Staging of mediastinal non-small-cell lung cancer with FDG-PET, et and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-7.
21. Weder W, Schmid RA, Bruchhaus A et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998; 66: 886-92.